Pharmacist's Role in Enhancing Multiple Myeloma Care
January 17th 2024Kristen Peterson, PharmD, BCOP, discusses how pharmacists optimize quality of life for patients with multiple myeloma, manage treatment adverse effects, and adapt amid health care shortages while staying updated on the latest advancements for comprehensive patient care.
Navigating Myelofibrosis Transitions
January 17th 2024Robert Mancini, PharmD, and Victoria Nachar, PharmD, discuss strategies and resources for smooth inpatient to outpatient transitions in myelofibrosis care, highlighting medication reconciliation, financial assistance, and the need for dedicated support staff.
Challenges in Outpatient Transition For Myelofibrosis Care
January 17th 2024Experts discuss obstacles faced while transitioning myelofibrosis patients from inpatient to outpatient care, emphasizing communication, access to medication, and the need for standardized medication reconciliation protocols.
Navigating CLL Management: Insights from a Clinical Pharmacist at Mount Sinai Hospital
January 17th 2024Kyle Farina, PharmD, BCPS, BCOP, addresses the multifaceted role of pharmacists in CLL management, including their role in patient care, treatment decision support, and addressing safety considerations.
Multiple Myeloma Care: Pharmacist Team Collaboration
January 3rd 2024Kristen Peterson, PharmD, BCOP, reviews how pharmacists collaborate with health care teams to optimize patient care through treatment insight, coordination, and adverse effects management, in addition to ensuring medication accessibility for better outcomes.